People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MediaMorph Inc | — | Other Technology | Series B | $38.0M | $121.8M | 2009 |
| Allosteric Bioscience, Inc. | — | Pharmaceuticals | Pre-Seed | $920K | $18.7M | 2021 |
Bruce Meyers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Meyers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bob Greene | 1 | 5 |
| Robert Gardos | 1 | 3 |
| Nomi Bergman | 1 | 2 |
| Shahid Khan | 1 | 2 |
| Michael Arrieta | 1 | 2 |
| Jim Riley | 1 | 2 |
| Kent Jarvi | 1 | 2 |
| Steve Pitts | 1 | 1 |
| Miron Bergman Nomi | 1 | 1 |
| Stewart Till | 1 | 1 |
| Michael Sid | 1 | 1 |
| Paul Giordano | 1 | 1 |
| Barry Baker | 1 | 1 |
| Laraine Mancini | 1 | 1 |
| Jonathan Lerner | 1 | 1 |
| Robert Toms | 1 | 1 |
| Tsvi Gal | 1 | 1 |
| Michael Huseby | 1 | 1 |
| Wahid Hamid | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.